Health Care · Surgical & Medical Instruments & Apparatus · Nasdaq · CIK 1227636 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $1.82Day −2.67%Mkt cap $127M1Y −59.3%Off 52W high −62.5%Vol (1Y) 107.3%
Daily closing price, split-adjusted to the current basis; 3y shown of 2,026 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest13.5% of sh out |
| Days to cover7.8d |
| 13F net flow (QoQ)+0.34% |
| Top-10 13F concentration82.9% |
| Next report (est.)2026-08-04 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$151.9M |
| Earnings (TTM)-$37.1M |
| ROE−155.7% |
| Net margin−26.1% |
| Debt / equity2.94× |
| Sales growth 3Y31.7% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+31.9% |
| 1Y−59.3% |
| 3Y−7.6% |
| 5Y−86.2% |
| Since incept. (ann.)−28.6% |
Total return through 2026-07-29 · series begins 2018-06-28. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)107.3% |
| Ann. volatility (3Y)108.5% |
| Sharpe (1Y)−0.34 |
| Sharpe (3Y)0.55 |
| Max drawdown (1Y)−74.7% |
| Max drawdown (3Y)−87.3% |
| Beta (3Y vs SPY)1.30 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| Madryn Asset Management, LP | 18.5M | $27M | 26.67% | +0.0% |
| UBS Group AG | 2.9M | $4M | 4.14% | +10.1% |
| Balyasny Asset Management L.P. | 2.7M | $4M | 3.96% | +7.5% |
| BlackRock, Inc. | 2.3M | $3M | 3.35% | −1.5% |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.0M | $3M | 2.96% | new |
| Lane Generational LLC | 1.8M | $3M | 2.56% | +4.1% |
| FourWorld Capital Management LLC | 1.5M | $2M | 2.15% | +59.9% |
| MASTERS CAPITAL MANAGEMENT LLC | 1.0M | $1M | 1.44% | +0.0% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-05 | −$0.16 | — | $34.5M | +7.8% |
| 2025-12-31 | 2026-03-17 | — | — | $41.8M | +85.8% |
| 2025-09-30 | 2025-11-04 | −$0.13 | — | $37.4M | +101.2% |
| 2025-06-30 | 2025-08-05 | −$0.15 | — | $38.2M | +131.5% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-04 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
Service 58% · Product 42%
product & service · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
